197 related articles for article (PubMed ID: 12195448)
41. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
42. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics.
Reiber H
Restor Neurol Neurosci; 2003; 21(3-4):79-96. PubMed ID: 14530572
[TBL] [Abstract][Full Text] [Related]
43. Increased CSF/serum albumin ratio: a recurrent finding in violent offenders.
Anckarsäter H; Forsman A; Blennow K
Acta Neurol Scand; 2005 Jul; 112(1):48-50. PubMed ID: 15932356
[TBL] [Abstract][Full Text] [Related]
44. Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis.
Meixensberger S; Bechter K; Dersch R; Feige B; Maier S; Schiele MA; Runge K; Denzel D; Nickel K; Spieler D; Urbach H; Prüss H; Domschke K; Tebartz van Elst L; Endres D
Fluids Barriers CNS; 2020 Nov; 17(1):67. PubMed ID: 33176794
[TBL] [Abstract][Full Text] [Related]
45. [Diagnostic value of the determination of albumin and immunoglobulin G concentrations in cerebrospinal fluid].
Lutz W; Jazdzewski B; Pawlak J
Wiad Lek; 1980 Dec; 33(24):1973-8. PubMed ID: 7245761
[No Abstract] [Full Text] [Related]
46. [Association of blood and cerebrospinal fluid IgG contents and severity of craniocerebral injury].
Li W; Xu RX; Zhang J; Chen SC; Fa ZQ; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):703-4. PubMed ID: 16762890
[TBL] [Abstract][Full Text] [Related]
47. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
[TBL] [Abstract][Full Text] [Related]
48. Reference intervals for feline cerebrospinal fluid: biochemical and serologic variables, IgG concentration, and electrophoretic fractionation.
Rand JS; Parent J; Jacobs R; Johnson R
Am J Vet Res; 1990 Jul; 51(7):1049-54. PubMed ID: 2167619
[TBL] [Abstract][Full Text] [Related]
49. Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity.
Hegen H; Auer M; Zeileis A; Deisenhammer F
Clin Chem Lab Med; 2016 Feb; 54(2):285-92. PubMed ID: 26079822
[TBL] [Abstract][Full Text] [Related]
50. Conditions of iodine contrast transfer from lumbosacral CSF to blood.
Seyfert S; Koch HC; Kunzmann V
J Neurol Sci; 2003 Jan; 206(1):85-90. PubMed ID: 12480090
[TBL] [Abstract][Full Text] [Related]
51. Quantitative relationships of the fourth complement component in human cerebrospinal fluid.
Cova JL; Propp RP; Barron KD
J Lab Clin Med; 1977 Mar; 89(3):615-21. PubMed ID: 402433
[TBL] [Abstract][Full Text] [Related]
52. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.
Blennow K; Fredman P; Wallin A; Gottfries CG; Långström G; Svennerholm L
Eur Neurol; 1993; 33(2):126-8. PubMed ID: 8467818
[TBL] [Abstract][Full Text] [Related]
53. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?
Garges HP; Moody MA; Cotten CM; Smith PB; Tiffany KF; Lenfestey R; Li JS; Fowler VG; Benjamin DK
Pediatrics; 2006 Apr; 117(4):1094-100. PubMed ID: 16585303
[TBL] [Abstract][Full Text] [Related]
54. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease.
Olsson JE; Pettersson B
Acta Neurol Scand; 1976 Apr; 53(4):308-22. PubMed ID: 1266574
[TBL] [Abstract][Full Text] [Related]
55. Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury.
Kirchhoff C; Buhmann S; Braunstein V; Leidel BA; Vogel T; Kreimeier U; Mutschler W; Biberthaler P
Eur J Med Res; 2008 Nov; 13(11):511-6. PubMed ID: 19073387
[TBL] [Abstract][Full Text] [Related]
56. Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes.
Kobessho H; Oishi K; Hamaguchi H; Kanda F
Eur Neurol; 2008; 60(3):132-6. PubMed ID: 18628631
[TBL] [Abstract][Full Text] [Related]
57. SGA and measures for muscle mass and strength in surgical Vietnamese patients.
Pham NV; Cox-Reijven PL; Wodzig WK; Greve JW; Soeters PB
Nutrition; 2007 Apr; 23(4):283-91. PubMed ID: 17350806
[TBL] [Abstract][Full Text] [Related]
58. Spinal anaesthesia with 0.5% isobaric bupivacaine in patients with diabetes mellitus: the influence of CSF composition on sensory and motor block.
Echevarria M; Hachero A; Martinez A; Ramallo E; García-Bernal D; Ramos M; Fernández A
Eur J Anaesthesiol; 2008 Dec; 25(12):1014-9. PubMed ID: 18990259
[TBL] [Abstract][Full Text] [Related]
59. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.
Brettschneider J; Claus A; Kassubek J; Tumani H
J Neurol; 2005 Sep; 252(9):1067-73. PubMed ID: 15789126
[TBL] [Abstract][Full Text] [Related]
60. Assessing cerebrospinal fluid abnormalities in neurosyphilis patients without human immunodeficiency virus infection.
Liu LL; Zhang HL; Huang SJ; Liu L; Tong ML; Lin LR; Chen YY; Xi Y; Guo XJ; Zhang YF
Int Immunopharmacol; 2013 Dec; 17(4):1120-4. PubMed ID: 24459685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
